A recent case series from a phase II basket trial reported a significant response in one out of two squamous cell vaginal cancer patients with positive PD-L1-CPS, while the other patient showed progressive disease despite a positive PD-L1 CPS [10]. The gene discussed is CD274; the disease is vaginal squamous cell carcinoma.